Given that ETS-FLI transcriptional activity can be regulated by LSD1 in other cancers, our results similarly demonstrated that LSD1 inhibition could repress FLI target genes related to angiogenesis and migration, thereby promoting cancer progression or higher histological grading [21]. This evidence concerns the gene KDM1A and cancer.